Point72 Asset Management, L.P. - PROQR THRAPEUTICS N V ownership

PROQR THRAPEUTICS N V's ticker is PRQR and the CUSIP is N71542109. A total of 69 filers reported holding PROQR THRAPEUTICS N V in Q3 2021. The put-call ratio across all filers is 1.13 and the average weighting 0.1%.

Quarter-by-quarter ownership
Point72 Asset Management, L.P. ownership history of PROQR THRAPEUTICS N V
ValueSharesWeighting
Q4 2021$3,693,000
-3.7%
461,000
+0.7%
0.02%
-11.8%
Q3 2021$3,833,000
-61.9%
457,900
-69.9%
0.02%
-63.8%
Q1 2021$10,059,000
+502850.0%
1,521,800
+1521700.0%
0.05%
Q2 2015$2,000
-96.4%
100
-96.0%
0.00%
Q1 2015$55,0002,5000.00%
Other shareholders
PROQR THRAPEUTICS N V shareholders Q3 2021
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 2,401,570$14,602,0002.94%
DAFNA Capital Management LLC 1,237,400$7,523,0002.17%
RTW INVESTMENTS, LP 4,902,785$29,809,0000.84%
Kerrisdale Advisers, LLC 453,182$2,755,0000.31%
COWEN AND COMPANY, LLC 300,042$1,824,0000.30%
Artal Group S.A. 1,259,177$7,656,0000.21%
ADAGE CAPITAL PARTNERS GP, L.L.C. 4,550,062$27,664,0000.07%
ALTRINSIC GLOBAL ADVISORS LLC 221,360$1,346,0000.06%
FRANKLIN STREET ADVISORS INC /NC 60,000$365,0000.04%
JENNISON ASSOCIATES LLC 2,625,514$15,963,0000.01%
View complete list of PROQR THRAPEUTICS N V shareholders